Inherited peripheral neuropathy

Seminars in Neurology

Volumn 19, Issue 4, 1999, Pages 353-362

  Keller, Marcel P ^a   Chance, Phillip F ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Charcot Marie Tooth neuropathy (CMT); Dejerine Sottas disease; Peripheral neuropathy

Indexed keywords

CONNEXIN 32; GENE PRODUCT; MYELIN PROTEIN;

AUTOSOMAL DOMINANT INHERITANCE; CHROMOSOME MAP; DEMYELINATION; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; MYOTATIC REFLEX; NERVE CONDUCTION; PERIPHERAL NEUROPATHY; POINT MUTATION; PRIORITY JOURNAL; REVIEW;

EID: 0033400053     PISSN: 02718235     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1040850     Document Type: Review

References (110)

1. Skre H. Genetic and clinical aspects of Charcot-Marie-Tooth's disease. Clin Genet 1974;6:98-118
2. Dyck PJ, Chance PF, Leho RV, Carney JA. Hereditary motor and sensory neuropathies. In: Dyck PJ, Thomas PJ, Griffin JW, Low PA, Poduslo JF, eds. Peripheral Neuropathy. Philadelphia: WB Saunders, 1993:1094-1136
3. Raeymaekers P, Timmerman V, De Jonghe P, Swerts L, Gheuens J, Martin JJ, et al. Localization of the mutation in an extended family with Charcot-Marie-Tooth neuropathy (HMSN I). Am J Hum Genet 1989;45:953-958
4. Chance PF, Bird TD, O'Connell P, Lipe H, Lalouel JM, Leppert M. Genetic linkage and heterogeneity in type I Charcot-Marie-Tooth disease (hereditary motor and sensory neuropathy type I). Am J Hum Genet 1990;47:915-925
5. McAlpine PJ, Feasby TE, Hahn AF, Komarnicki L, James S, Guy C, et al. Localization of a locus for Charcot-Marie-Tooth neuropathy type Ia (CMT1A) to chromosome 17. Genomics 1990;7:408-415
6. Middleton-Price HR, Harding AE, Monteiro C, Berciano J, Malcolm S. Linkage of hereditary motor and sensory neuropathy type I to the pericentromeric region of chromosome 17. Am J Hum Genet 1990;46:92-94
7. Patel PI, Franco B, Garcia C, Slaugenhaupt SA, Nakamura Y, Ledbetter DH, et al. Genetic mapping of autosomal dominant Charcot-Marie-Tooth disease in a large French-Acadian kindred: Identification of new linked markers on chromosome. Am J Hum Genet 1990;46:801-809
8. Vance JM, Barker D, Yamaoka LH, Stajich JM, Loprest L, Hung WY, et al. Localization of Charcot-Marie-Tooth disease type 1a (CMT1A) to chromosome 17p11.2. Genomics 1991;9:623-628
9. Lupski JR, de Oca-Luna RM, Slaugenhaupt S, Pentao L, Guzzetta V, Trask BJ, et al. DNA duplication associated with Charcot-Marie-Tooth disease type 1A. Cell 1991;66:219-232
10. Raeymaekers P. Timmerman V, Nelis E, Van Hul W, De Jonghe P, Martin J, et al. Estimation of the size of the chromosome 17p11.2 duplication in Charcot-Marie-Tooth neuropathy type 1a (CMT1a). HMSN Collaborative Research Group. J Med Genet 1992;29:5-11
11. Raeymaekers P, Timmerman V, Nelis E, De Jonghe P, Hoogendijk JE, Baas F, et al. Duplication in chromosome 17p11.2 in Charcot-Marie-Tooth neuropathy type 1A (CMT 1A). Neuromuscul Disord 1991;1:93-97
12. Wright EC, Goldgar DE, Fain PR, Barker DF, Skolnick MH. A genetic map of human chromosome 17p. Genomics 1990;7: 103-109
13. Hoogendijk JE. Hensels GW, Gabreels-Festen AA, Gabreels FJ, Janssen EA, de Jonghe P, et al. De-novo mutation in hereditary motor and sensory neuropathy type I. Lancet 1992;339: 1081-1082
14. Blair IP, Nash J, Gordon MJ, Nicholson GA. Prevalence and origin of de novo duplications in Charcot-Marie-Tooth disease type 1A: First report of a de novo duplication with a maternal origin. Am J Hum Genet 1996;58:472-476
15. Falconer DS. Two new mutants, "Trembler" and "Reeler" with neurological actions in the mouse (Mus musculus L.). J Genet 1951;50:192-201
16. Davisson MT, Roderick TH. Status of the linkage map of the mouse. Cytogenet Cell Genet 1978;22:552-557
17. Buchberg AM, Brownell E, Nagata S, Jenkins NA, Copeland NG. A comprehensive genetic map of murine chromosome 11 reveals extensive linkage conservation between mouse and humans. Genetics 1989;122:153-161
18. Suter U, Welcher AA, Ozcelik T, Snipes GJ, Kosaras B, Francke U, et al. Trembler mouse carries a point mutation in a myelin gene. Nature 1992;356:241-244
19. Manfioletti G, Ruaro ME, Del Sal G, Philipson L, Schneider C. A growth arrest-specific (gas) gene codes for a membrane protein. Mol Cell Biol 1990;10:2924-2930
20. Spreyer P, Kuhn G, Hanemann CO, Gillen C, Schaal H, Kuhn R, et al. Axon-regulated expression of a Schwann cell transcript that is homologous to a 'growth arrest-specific' gene. Embo J 1991;10:3661-3668
21. Welcher AA, Suter U, De Leon M, Snipes GJ, Shooter EM. A myelin protein is encoded by the homologue of a growth arrest-specific gene. Proc Natl Acad Sci U S A 1991;88:7195-7199
22. Matsunami N, Smith B, Ballard L, Lensch MW, Robertson M, Albertsen H, et al. Peripheral myelin protein-22 gene maps in the duplication in chromosome 17p11.2 associated with Charcot-Marie-Tooth 1A. Nat Genet 1992;1:176-179
23. Patel PI, Roa BB, Welcher AA, Schoener-Scott R, Trask BJ, Pentao L, et al. The gene for the peripheral myelin protein PMP-22 is a candidate for Charcot-Marie-Tooth disease type 1A. Nat Genet 1992;1:159-165
24. Timmerman V, Nelis E, Van Hul W, Nieuwenhuijsen BW, Chen KL, Wang S, et al. The peripheral myelin protein gene PMP-22 is contained within the Charcot-Marie-Tooth disease type 1A duplication. Nat Genet 1992;1:171-175
25. Valentijn LJ, Bolhuis PA, Zorn I, Hoogendijk JE, van den Bosch N, Hensels GW, et al. The peripheral myelin gene PMP-22/GAS-3 is duplicated in Charcot-Marie-Tooth disease type 1A. Nat Genet 1992;1:166-170
26. Snipes GJ, Suter U, Welcher AA, Shooter EM. Characterization of a novel peripheral nervous system myelin protein (PMP-22/SR13). J Cell Biol 1992;117:225-238
27. Suter U, Snipes GJ, Schoener-Scott R, Welcher AA, Pareek S, Lupski JR, et al. Regulation of tissue-specific expression of alternative peripheral myelin protein-22 (PMP22) gene transcripts by two promoters. J Biol Chem 1994;269;25795-25808
28. Yoshikawa H, Nishimura T, Nakatsuji Y, Fujimura H, Himoro M, Hayasaka K, et al. Elevated expression of messenger RNA for peripheral myelin protein 22 in biopsied peripheral nerves of patients with Charcot-Marie-Tooth disease type 1A. Ann Neurol 1994;35:445-450
29. Gabriel JM, Erne B, Pareyson D, Sghirlanzoni A, Taroni F, Steck AJ. Gene dosage effects in hereditary peripheral neuropathy. Expression of peripheral myelin protein 22 in Charcot-Marie-Tooth disease type 1A and hereditary neuropathy with liability to pressure palsies nerve biopsies. Neurology 1997; 49:1635-1640
30. Valentijn LJ, Baas F, Wolterman RA, Hoogendijk JE, van den Bosch NH, Zorn I, et al. Identical point mutations of PMP-22 in Trembler-J mouse and Charcot-Marie-Tooth disease type 1A. Nat Genet 1992;2:288-291
31. Roa BB, Garcia CA, Suter U, Kulpa DA, Wise CA, Mueller J, et al. Charcot-Marie-Tooth disease type 1A. Association with a spontaneous point mutation in the PMP22 gene. New Engl J Med 1993;329:96-101
32. Navon R, Seifried B, Gal-On NS, Sadeh M. A new point mutation affecting the fourth transmembrane domain of PMP22 results in severe de novo Charcot-Marie-Tooth disease. Hum Genet 1996;97:685-687
33. Gabreels-Festen AA, Bolhuis PA, Hoogendijk JE, Valentijn LJ, Eshuis EJ, Gabreels FJ. Charcot-Marie-Tooth disease type 1A: Morphological phenotype of the 17p duplication versus PMP22 point mutations. Acta Neuropathol 1995;90:645-649
34. Wise CA, Garcia CA, Davis SN, Heju Z, Pentao L, Patel PI, et al. Molecular analyses of unrelated Charcot-Marie-Tooth (CMT) disease patients suggest a high frequency of the CMTIA duplication. Am J Hum Genet 1993;53:853-863
35. Stebbins NB, Conneally PM. Linkage of dominantly inherited Charcot-Marie-Tooth neuropathy to the Duffy locus in an Indian family. Am J Hum Genet 1982;34:388-394
36. Hayasaka K, Nanao K, Tahara M, Sato W, Takada G, Miura M, et al. Isolation and sequence determination of cDNA encoding the major structural protein of human peripheral myelin. Biochem Biophys Res Commun 1991;180:515-518
37. Hayasaka K, Himoro M, Sato W, Takada G, Uyemura K, Shimizu N, et al. Charcot-Marie-Tooth neuropathy type 1B is associated with mutations of the myelin P0 gene. Nat Genet 1993;5:31-34
38. Kulkens T, Bolhuis PA, Wolterman RA, Kemp S, te Nijenhuis S, Valentijn LJ, et al. Deletion of the serine 34 codon from the major peripheral myelin protein P0 gene in Charcot-Marie-Tooth disease type 1B. Nat Genet 1993;5:35-39
39. Hayasaka K, Takada G, Ionasescu VV. Mutation of the myelin P0 gene in Charcot-Marie-Tooth neuropathy type 1B. Hum Mol Genet 1993;2:1369-1372
40. Hayasaka K, Ohnishi A, Takada G, Fukushima Y, Murai Y. Mutation of the myelin P0 gene in Charcot-Marie-Tooth neuropathy type 1. Biochem Biophys Res Commun 1993;194: 1317-1322
41. Warner LE, Hilz MJ, Appel SH, Killian JM, Kolodry EH, Karpati G, et al. Clinical phenotypes of different MPZ (P0) mutations may include Charcot-Marie-Tooth type 1B, Dejerine-Sottas, and congenital hypomyelination. Neuron 1996;17:451-460
42. Roa BB, Warner LE, Garcia CA, Russo D, Lovelace R, Chance PF, et al. Myelin protein zero (MPZ) gene mutations in nonduplication type 1 Charcot-Marie-Tooth disease. Hum Mutat 1996;7:36-45
43. Gabreels-Festen AA, Hoogendijk JE, Meijerink PH, Gabreels FJ, Bolhuis PA, van Beersum S, et al. Two divergent types of nerve pathology in patients with different P0 mutations in Charcot-Marie-Tooth disease. Neurology 1996;47:761-765
44. Nelis E, Timmerman V, De Jonghe P, Vandenberghe A, Pham-Dinh D, Dautigny A, et al. Rapid screening of myelin genes in CMT1 patients by SSCP analysis: Identification of new mutations and polymorphisms in the P0 gene. Hum Genet 1994; 94:653-657
45. Lemke G. The molecular genetics of myelination: An update. Glia 1993;7:263-271
46. Roa BB, Dyck PJ, Marks HG, Chance PF, Lupski JR. Dejerine-Sottas syndrome associated with point mutation in the peripheral myelin protein 22 (PMP22) gene. Nat Genet 1993; 5:269-273
47. Hayasaka K, Himoro M, Sawaishi Y, Nanao K, Takahashi T, Takada G, et al. De novo mutation of the myelin P0 gene in Dejerine-Sottas disease (hereditary motor and sensory neuropathy type III). Nat Genet 1993;5:266-268
48. Stogbauer F, Young P, Wiebusch H, Timmerman V, Kuhlenbaumer G, Nelis E, et al. Absence of mutations in peripheral myelin protein-22, myelin protein zero, and connexin 32 in autosomal recessive Dejerine-Sottas syndrome. Neurosci Lett 1998;240:1-4
49. Windebank AJ, Schenone A, Dewald GW. Hereditary neuropathy with liability to pressure palsies and inherited brachial plexus neuropathy - two genetically distinct disorders. Mayo Clin Proc 1995;70:743-746
50. Dyck PJ, Oviatt KF, Lambert EH. Intensive evaluation of referred unclassified neuropathies yields improved diagnosis. Ann Neurol 1981;10:222-226
51. Madrid R, Bradley WG. The pathology of neuropathies with focal thickening of the myelin sheath (tomaculous neuropathy): Studies on the formation of the abnormal myelin sheath. J Neurol Sci 1975;25:415-448
52. Chance PF, Alderson MK, Leppig KA, Lensch MW, Matsunami N, Smith B, et al. DNA deletion associated with hereditary neuropathy with liability to pressure palsies. Cell 1993;72: 143-151
53. Mariman EC, Gabreels-Festen AA, van Beersum SE, Jongen PJ, Ropers HH, Gabreels FJ. Gene for hereditary neuropathy with liability to pressure palsies (HNPP) maps to chromosome 17 at or close to the locus for HMSN type 1. Hum Genet 1993;92: 87-90
54. Le Guern E, Sturtz F, Gugenheim M, Gouider R, Bonnebouche C, Ravise N, et al. Detection of deletion within 17p11.2 in 7 French families with hereditary neuropathy with liability to pressure palsies (HNPP). Cytogenet Cell Genet 1994;65: 261-264
55. Schenone A, Nobbio L, Caponnetto C, Abbruzzese M, Mandich P, Bellone E, et al. Correlation between PMP-22 messenger RNA expression and phenotype in hereditary neuropathy with liability to pressure palsies. Ann Neurol 1997;42:866-872
56. Nicholson GA, Valentijn LJ, Cherryson AK, Kennerson ML, Bragg TL, DeKroon RM, et al. A frame shift mutation in the PMP22 gene in hereditary neuropathy with liability to pressure palsies. Nat Genet 1994;6:263-266
57. Chance PF, Abbas N, Lensch MW, Pentao L, Roa BB, Patel PI, et al. Two autosomal dominant neuropathies result from reciprocal DNA duplication/deletion of a region on chromosome 17. Hum Mol Genet 1994;3:223-228
58. Lopes J, Vandenberghe A, Tardieu S, Ionasescu V, Levy N, Wood N, et al. Sex-dependent rearrangements resulting in CMT1A and HNPP. Nat Genet 1997;17:136-137
59. Lopes J, Ravise N, Vandenberghe A, Palau F, Ionasescu V, Mayer M, et al. Fine mapping of de novo CMT1A and HNPP rearrangements within CMT1A-REPs evidences two distinct sex-dependent mechanisms and candidate sequences involved in recombination. Hum Mol Genet 1998;7:141-148
60. Kiyosawa H, Chance PF. Primate origin of the CMT1A-REP repeat and analysis of a putative transposon-associated recombinational hotspot. Hum Mol Genet 1996;5:745-753
61. Reiter LT, Murakami T, Koeuth T, Gibbs RA, Lupski JR. The human COX10 gene is disrupted during homologous recombination between the 24 kb proximal and distal CMT1A-REPs. Hum Mol Genet 1997;6:1595-1603
62. Reiter LT, Murakami T, Koeuth T, Pentao L, Munzy DM, Gibbs RA, et al. A recombination hotspot responsible for two inherited peripheral neuropathies is located near a mariner transposon-like element. Nat Genet 1996;12:288-297
63. Lopes J, LeGuern E, Gouider R, Tardieu S, Abbas N, Birouk N, et al. A Recombination hot spot in a 3.2-kb region of the Charcot-Marie-Tooth type 1A repeat sequences: New tools for molecular diagnosis of hereditary neuropathy with liability to pressure palsies and of Charcot-Marie-Tooth type 1A. French CMT Collaborative Research Group. Am J Hum Genet 1996;58:1223-1230
64. Yamamoto M, Yasuda T, Hayasaka K, Ohnishi A, Yoshikawa H, Yanagihara T, et al. Locations of crossover breakpoints within the CMT1A-REP repeat in Japanese patients with CMT1A and HNPP. Hum Genet 1997;99:151-154
65. Timmerman V, Rautenstrauss B, Reiter LT, Koeuth T, Lofgren A, Liehr T, et al. Detection of the CMT1A/HNPP recombination hotspot in unrelated patients of European descent. J Med Genet 1997;34:43-49
66. Yamamoto M, Keller MP, Yasuda T, Hayasaka K, Ohnishi A, Yoshikawa H, et al. Clustering of CMT1A duplication breakpoints in a 700 bp interval of the CMT1A-REP repeat. Hum Mutat 1998;11:109-113
67. Reiter LT, Hastings PJ, Nelis E, De Jonghe P, Van Broeckhoven C, Lupski JR. Human meiotic recombination products revealed by sequencing a hotspot for homologous strand exchange in multiple HNPP deletion patients. Am J Hum Genet 1998;62:1023-1033
68. Kiyosawa H, Lensch MW, Chance PF. Analysis of the CMT1A-REP repeat: Mapping crossover breakpoints in CMT1A and HNPP. Hum Mol Genet 1995;4:2327-2334
69. Kennerson ML, Nassif NT, Dawkins JL, DeKroon RM, Yang JG, Nicholson GA. The Charcot-Marie-Tooth binary repeat contains a gene transcribed from the opposite strand of a partially duplicated region of the COX10 gene. Genomics 1997;46:61-69
70. Harding AE, Thomas PK. Genetic aspects of hereditary motor and sensory neuropathy (types I and II). J Med Genet 1980;17:329-336
71. Ben Othmane K, Middleton LT, Loprest LJ, Wilkinson KM, Lennon F, Rozear MP, et al. Localization of a gene (CMT2A) for autosomal dom nant Charcot-Marie-Tooth disease type 2 to chromosome 1p and evidence of genetic heterogeneity. Genomics 1993;17:370-375
72. Saito M, Hayashi Y, Suzuki T, Tanaka H, Hozumi I, Tsuji S. Linkage mapping of the gene for Charcot-Marie-Tooth disease type 2 to chromosome 1p (CMT2A) and the clinical features of CMT2A. Neurology 1997;49:1630-1635
73. Kwon JM, Elliott JL, Yee WC, Ivanovich J, Scavarda NJ, Moolsintong PJ, et al. Assignment of a second Charcot-Marie-Tooth type II locus to chromosome 3q. Am J Hum Genet 1995;57:853-858
74. Dyck PJ, Litchy WJ, Minnerath S, Bird TD, Chance PF, Schaid DJ, et al. Hereditary motor and sensory neuropathy with diaphragm and vocal cord paresis. Ann Neurol 1994;35:608-615
75. Yoshioka R, Dyck PJ, Chance PF. Genetic heterogeneity in Charcot-Marie-Tooth neuropathy type 2. Neurology 1996;46: 569-571
76. Ionasescu V, Searby C, Sheffield VC, Roklina T, Nishimura D, Ionasescu R. Autosomal dominant Charcot-Marie-Tooth axonal neuropathy mapped on chromosome 7p (CMT2D). Hum Mol Genet 1996;5:1375-1375
77. Timmerman V, De Jonghe P, Spoelders P, Simokovic S, Lofgren A, Nelis E, et al. Linkage and mutation analysis of Charcot-Marie-Tooth neuropathy type 2 families with chromosomes 1p35-p36 and Xq13. Neurology 1996;46:1311-1318
78. Allan W. Relation of hereditary pattern to clinical severity as illustrated by peroneal atrophy. Arch Intern Med 1939;63:1123-1131
79. Fryns JP, Van den Berghe H. Sex-linked recessive inheritance in Charcot-Marie-Tooth disease with partial clinical manifestations in female carriers. Hum Genet 1980;55:413-415
80. Gal A, Mucke J, Theile H, Wieacker PF, Ropers HH, Wienker TF. X-linked dominant Charcot-Marie-Tooth disease: Suggestion of linkage with a cloned DNA sequence from the proximal Xq. Hum Genet 1985;70:38-42
81. Fischbeck KH, ar-Rushdi N, Pericak-Vance M, Rozear M, Roses AD, Fryns JP. X-linked neuropathy: Gene localization with DNA probes. Ann Neurol 1986;20:527-532
82. Ionasescu VV, Trofatter J, Haines JL, Ionasescu R, Searby C. Mapping of the gene for X-linked dominant Charcot-Marie-Tooth neuropathy. Neurology 1992;42:903-908
83. Mostacciuolo ML, Muller E, Fardin P, Micaglio GF, Bardoni B, Guioli S, et al. X-linked Charcot-Marie-Tooth disease. A linkage study in a large family by using 12 probes of the pericentromeric region. Hum Genet 1991;87:23-27
84. Ionasescu VV, Trofatter J, Haines JL, Summers AM, Ionasescu R, Searby C. Heterogeneity in X-linked recessive Charcot-Marie-Tooth neuropathy. Am J Hum Genet 1991;48: 1075-1083
85. Bergoffen J, Trofatter J, Pericak-Vance MA, Haines JL, Chance PF, Fischbeck KH. Linkage localization of X-linked Charcot-Marie-Tooth disease. Am J Hum Genet 1993;52: 312-318
86. Fain PR, Barker DF, Chance PF. Refined genetic mapping of X-linked Charcot-Marie-Tooth neuropathy. Am J Hum Genet 1994;54:229-235
87. Bergoffen J, Scherer SS, Wang S, Scott MO, Bone LJ, Paul DL, et al. Connexin mutations in X-linked Charcot-Marie-Tooth disease. Science 1993;262:2039-2042
88. Snipes GJ, Suter U. Molecular anatomy and genetics of myelin proteins in the peripheral nervous system. J Anat 1995;186: 483-494
89. Fairweather N, Bell C, Cochrane S, Chelly J, Wang S, Mostacciuolo ML, et al. Mutations in the connexin 32 gene in X-linked dominant Charcot-Marie-Tooth disease (CMTX1). Hum Mol Genet 1994;3:29-34
90. Ionasescu V, Searby C, Ionasescu R. Point mutations of the connexin32 (GJB1) gene in X-linked dominant Charcot-Marie-Tooth neuropathy. Hum Mol Genet 1994;3:355-358
91. Ionasescu VV, Searby C, Ionsasescu R, Neuhaus IM, Werner R. Mutations of the noncoding region of the connexin32 gene in X-linked dominant Charcot-Marie-Tooth neuropathy. Neurology 1996;47:541-544
92. Bone LJ, Deschenes SM, Balice-Gordon RJ, Fischbeck KH, Scherer SS. Connexin32 and X-linked Charcot-Marie-Tooth disease. Neurobiol Dis 1997;4:221-230
93. Deschenes SM, Walcott JL, Wexler TL, Scherer SS, Fischbeck KH. Altered trafficking of mutant connexin32. J Neurosci 1997;17:9077-9084
94. Yoshimura T, Sataka M, Ohnishi A, Tsutsumi Y, Fujikura Y. Mutations of connexin32 in Charcot-Marie-Tooth disease type X interfere with cell-to-cell communication but not cell proliferation and myelin-specific gene expression. J Neurosci Res 1998;51:154-161
95. Warner LE, Mancias P, Butler IJ, McDonald CM, Keppen L, Koob KG, et al. Mutations in the early growth response 2 (EGR2) gene are associated with hereditary myelinopathies. Nat Genet 1998;18:382-384
96. Zorick TS, Syroid DE, Arroyo E, Scherer SS, Lemke G. The Transcription factors SCIP and Krox-20 mark distinct stages and cell fates in Schwann cell differentiation. Mol Cell Neurosci 1996;8:129-145
97. Ben Othmane K, Hentati F, Lennon F, Ben Hamida C, Blel S, Roses AD, et al. Linkage of a locus (CMT4A) for autosomal recessive Charcot-Marie-Tooth disease to chromosome 8q. Hum Mol Genet 1993;2:1625-1628
98. Ben Othmane KB, Loeb D, Hayworth-Hodgte R, Hentati F, Rao N, Roses A, et al. Physical and genetic mapping of the CMT4A locus and exclusion of PMP-2 as the defect in CMT4A. Genomics 1995;28:286-290
99. Bolino A, Brancolini V, Bono F, Bruni A, Gambardella A, Romeo G, et al. Localization of a gene responsible for autosomal recessive demyelinating neuropathy with focally folded myelin sheaths to chromosome 11q23 by homozygosity mapping and haplotype sharing. Hum Mol Genet 1996;5:1051-1054
100. Gambardella A, Bolino A, Muglia M, Valentino P, Bono F, Oliveri RL, et al. Genetic heterogeneity in autosomal recessive hereditary motor and sensory neuropathy with focally folded myelin sheaths (CMT4B). Neurology 1998;50:799-801
101. Denny-Brown D. Hereditary sensory radicular neuropathy. J Neurol Neurosurg Psychiatry 1951;14:237-252
102. Blair IP, Dawkins JL, Nicholson GA. Fine mapping of the hereditary sensory neuropathy type I locus on chromosome 9q22.1 ;raq22.3: Exclusion of GAS1 and XPA. Cytogenet Cell Genet 1997;78:140-144
103. Nicholson GA. Penetrance of the hereditary motor and sensory neuropathy Ia mutation: Assessment by nerve conduction studies. Neurology 1991;41:547-552
104. Ionasescu VV. Charcot-Marie-Tooth neuropathies: From clinical description to molecular genetics. Muscle Nerve 1995;18: 267-275
105. Zoidl G, Blass-Kampmann S, D'Urso D, Schmalenbach C, Muller HW. Retroviral-mediated gene transfer of the peripheral myelin protein PMP22 in Schwann cells: Modulation of cell growth. Embo J 1995;14:1122-1128
106. Adlkofer K, Martini R, Aguzzi A, Zielasek J, Toyka KV, Suter U. Hypermyelination and demyelinating peripheral neuropathy in Pmp22-deficient mice. Nat Genet 1995;11:274-280
107. Sahenk Z, Chen L, Mendell JR. Effects of PMP22 duplication and deletions on the axonal cytoskeleton. Ann Neurol 1999; 45:16-24
108. Naef R, Suter U. Impaired intracellular trafficking is a common disease mechanism of PMP22 point mutations in peripheral neuropathies. Neurobiol Dis 1999;6:1-14
109. o, the major structural protein of peripheral nerve myelin. Neuron 1996;17:435-449
110. Bruzzone R, Ressot C. Connexins, gap junctions and cell-cell signalling in the nervous system. Eur J Neurosci 1997;9:1-6